Structure based discovery of small molecules to regulate the activity of human insulin degrading enzyme.
<h4>Background</h4>Insulin-degrading enzyme (IDE) is an allosteric Zn(+2) metalloprotease involved in the degradation of many peptides including amyloid-β, and insulin that play key roles in Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM), respectively. Therefore, the u...
Main Authors: | Bilal Çakir, Onur Dağliyan, Ezgi Dağyildiz, İbrahim Bariş, Ibrahim Halil Kavakli, Seda Kizilel, Metin Türkay |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22355395/?tool=EBI |
Similar Items
-
Optimization based tumor classification from microarray gene expression data.
by: Onur Dagliyan, et al.
Published: (2011-02-01) -
Correction: Investigation of Real-Time Photorepair Activity on DNA via Surface Plasmon Resonance.
by: Rıza Kizilel, et al.
Published: (2012-01-01) -
Structure-based design and classifications of small molecules regulating the circadian rhythm period
by: Seref Gul, et al.
Published: (2021-09-01) -
Discovery of a small molecule that selectively destabilizes Cryptochrome 1 and enhances life span in p53 knockout mice
by: Seref Gul, et al.
Published: (2022-11-01) -
No major role for insulin-degrading enzyme in antigen presentation by MHC molecules.
by: Slobodan Culina, et al.
Published: (2014-01-01)